StockData
Anixa Biosciences Inc logo

Anixa Biosciences Inc (ANIX) income statement

ANIXNasdaqPharmaceutical PreparationsFiscal year ends October 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Jul 31, 2026Last filing: 10-Q on Sep 9, 2026Score 6/30
$2.71+0.04 (+1.50%)

Close on Nov 18, 2026Market cap $94.21MP/E –Yield –

Anixa Biosciences Inc income statement

Ratios

Latest available, balances at Jul 31, 2026

Profitability, FY

Gross margin
–
Operating margin
–
Net margin
–
Return on equity, FY2025
-62.2%

Financial strength

Current ratio
8.54
Debt to equity
–
Debt to assets
–
Cash to current liabilities
80.1%

Valuation

P/E ratio
–
Price to sales
–
Price to book
6.51
Dividend yield
–

See a number that looks wrong?